Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Eli Lilly plans to introduce its weight loss drug in China soon

    By Zhou Wenting | chinadaily.com.cn | Updated: 2024-12-06 19:24
    Share
    Share - WeChat
    The booth of US pharmaceutical company Eli Lilly and Co at the seventh China International Import Expo held in Shanghai in November 2024. [Photo provided to chinadaily.com.cn]

    The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its innovative weight loss therapy available to patients in China very soon.

    "At Lilly, we're committed to supporting individuals affected by obesity, which is a chronic disease that requires effective treatment options and long-term management," said Huzur Devletsah, president and general manager of Lilly China.

    Her comment came after Lilly announced the top-line results from the SURMOUNT-5 clinical trial that day, showing that its Zepbound (tirzepatide) provided a 47 percent greater relative weight loss compared to Wegovy (semaglutide) by Danish pharmaceutical company Novo Nordisk.

    Wegovy was marketed earlier than Zepbound, and is currently the world's best-selling GLP-1 weight loss medicine.

    Lilly said the trial results showed that on average, Zepbound led to a weight loss of 20.2 percent compared to 13.7 percent with Wegovy. A key competitiveness of Zepbound lies in that it is the only US FDA-approved product that activates both GLP-1 and GIP - two receptors playing key roles in regulating blood sugar and energy balance in the human body.

    GLP-1 therapies, originally used to treat type 2 diabetes, have gained popularity throughout the world due to their weight loss effect in recent years. Novo Nordisk and Lilly are currently the main global leaders.

    The companies' financial reports showed that in the first three quarters of this year, Wegovy's revenue was about $5.53 billion, a year-on-year increase of 77 percent, and Zepbound's revenue was nearly $3.02 billion after the figure exceeded $1 billion for the first time in the second quarter.

    British bank Barclays predicted that the global weight loss therapy market will grow to $150 billion by 2030. And according to the forecast of US consultancy Frost & Sullivan, the market size of GLP-1 medicines in China will exceed 50 billion yuan in 2030.

    Domestic medical experts said that such positive trial results may affect doctors' drug recommendations in clinical use, but which therapies to prescribe may be affected by multiple factors, including indications, prices, reimbursement policies, and patient preferences.

    In October, Lilly announced a roughly $200 million expansion of its manufacturing site in Suzhou, Jiangsu province, aiming to increase production of such innovative medicines.

    During a previous interview with media outlet ThePaper.cn, Zhou Xiaping, global senior vice-president of Novo Nordisk and president of Novo Nordisk China, said that with full confidence in its products, the company welcomes healthy competition in the field of GLP-1 medicines to jointly help more obese patients.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    亚洲熟妇无码八V在线播放| 人妻中文字幕无码专区| 69天堂人成无码麻豆免费视频| 久久久久中文字幕| 亚欧无码精品无码有性视频| 亚洲欧洲日产国码无码网站| 中文字幕你懂得| 亚洲欧美综合中文| 国产啪亚洲国产精品无码| 伊人久久精品无码二区麻豆| 精品亚洲欧美中文字幕在线看| 亚洲人成人无码网www国产| 日韩人妻无码中文字幕视频| 蜜桃AV无码免费看永久| 在线综合+亚洲+欧美中文字幕| 亚洲区日韩区无码区| 成在线人AV免费无码高潮喷水| 亚洲av无码专区在线播放 | 国产亚洲情侣一区二区无码AV| 亚洲永久无码3D动漫一区| 在线欧美天码中文字幕| 日本aⅴ精品中文字幕| 中文字幕亚洲男人的天堂网络| 少妇无码太爽了不卡视频在线看| 无码日韩人妻精品久久蜜桃| 亚洲精品无码av人在线观看| 国产午夜精华无码网站| 日韩va中文字幕无码电影| 中文字幕一区二区三区日韩精品| 久久中文骚妇内射| 久久亚洲精精品中文字幕| 亚洲Av无码乱码在线观看性色 | 国产午夜无码精品免费看动漫| 亚洲av无码一区二区三区不卡| 亚洲中文字幕无码中文字在线| 在人线AV无码免费高潮喷水| 亚洲AV无码欧洲AV无码网站| 亚洲Av综合色区无码专区桃色 | 91精品久久久久久无码| WWW插插插无码视频网站| 亚洲av中文无码|